SANUWAVE Health, Inc. (SNWV)

4.38USD -1.57% (-0.07)

Over 1M: -25.5%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

4.5 5 5.5
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Income: 1.5M Q3 '25 — Free Cash Flow: 556K Q3 '25 — Net Income: 10.3M Q4 '25 — Operating Income: 2M Q4 '25 — Free Cash Flow: 3.2M Q4 '25 — Net Income: 7.7M Q1 '26 — Operating Income: -1.1M Q1 '26 — Free Cash Flow: 374K Q1 '26 — Net Income: -1.4M Q2 '26 — Operating Income: -280K Q2 '26 — Free Cash Flow: 91K Q2 '26 — Net Income: -682K 0 2.5M 5M 7.5M 10M 12.5M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Operating Income Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.6
SBC / sales 13.3%
ROIC 8.3%
OE margin -3.7%
Gross margin 76.4%
OCF / EBIT 2.5×
ROA 43.4%
ROE 570.4%
ROCE 11.2%
FCF margin 9.6%
OCF margin 11.8%
Accruals 29.2%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

3.6
EV/EBIT 26.4×
EV/OE -33.2×
EV/GP 1.6×
P/E 2.4×
EV/Sales 1.2×
FCF yield 11.3%
P/C 4.0×
P/B 13.5×
Div. yield —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.3
RPO / sales 0.025×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

2.0
ND/EBITDA -0.31
Payout 0.0%
F-score 6.8 pts
Cash / Debt 0.36×
Debt payback 4.0 yr
Quick ratio 0.89×
Debt / Eq 9.4×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.0
Sales CAGR 4Y +35.6%
Sales/sh Y/Y +13.1%
EBIT Y/Y -65.6%
Sales Q/Q -3.1%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Shares change —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.